{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T03:45:44Z","timestamp":1788407144082,"version":"build-2803163510"},"reference-count":36,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.cgh.2022.09.028","type":"journal-article","created":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T03:06:49Z","timestamp":1664766409000},"page":"2560-2569.e15","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["The Spectrum and Impact of Metabolic Dysfunction in MAFLD: A Longitudinal Cohort Analysis of 32,683 Overweight and Obese Individuals"],"prefix":"10.1016","volume":"21","author":[{"given":"Kai En","family":"Chan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8297-1569","authenticated-orcid":false,"given":"Cheng Han","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clarissa Elysia","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingxuan","family":"Quek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwyneth","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi Jie","family":"Goh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca Wenling","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Tseng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manik","family":"Aggarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Nah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas","family":"Chee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen Yu","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sitong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiong-Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas W.S.","family":"Chew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yock Young","family":"Dan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Shadab","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mazen","family":"Noureddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun J.","family":"Sanyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Muthiah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2022.09.028_bib1","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/s41575-019-0144-8","article-title":"Past, present and future perspectives in nonalcoholic fatty liver disease","volume":"16","author":"Sanyal","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2022.09.028_bib2","article-title":"An observational data meta-analysis on the differences in prevalence and risk factors between MAFLD vs NAFLD","author":"Hui Lim","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2022.09.028_bib3","article-title":"2019 Global NAFLD prevalence: a systematic review and meta-analysis","author":"Le","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2022.09.028_bib4","doi-asserted-by":"crossref","DOI":"10.1111\/apt.16808","article-title":"Meta-analysis: analysis of mechanistic pathways in the treatment of non-alcoholic steatohepatitis\u2014evidence from a Bayesian network meta-analysis","volume":"55","author":"Ng","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"issue":"Suppl 2","key":"10.1016\/j.cgh.2022.09.028_bib5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/dom.14521","article-title":"A\u00a0clinical overview of non-alcoholic fatty liver disease: a guide to diagnosis, the clinical features, and complications\u2014what the non-specialist needs to know","volume":"24","author":"Muthiah","year":"2022","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.cgh.2022.09.028_bib6","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.4254\/wjh.v13.i11.1584","article-title":"Heterogeneity of non-alcoholic fatty liver disease: implications for clinical practice and research activity","volume":"13","author":"Pal","year":"2021","journal-title":"World J Hepatol"},{"key":"10.1016\/j.cgh.2022.09.028_bib7","doi-asserted-by":"crossref","first-page":"9935","DOI":"10.3390\/ijerph19169935","article-title":"Historical changes in weight classes and the influence of NAFLD prevalence: a population analysis of 34,486 individuals","volume":"19","author":"Nah","year":"2022","journal-title":"International Journal of Environmental Research and Public Health"},{"key":"10.1016\/j.cgh.2022.09.028_bib8","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease","volume":"158","author":"Eslam","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2022.09.028_bib9","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A\u00a0new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2022.09.028_bib10","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41575-020-0316-6","article-title":"From NAFLD to MAFLD: when pathophysiology succeeds","volume":"17","author":"Tilg","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2022.09.028_bib11","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgac321","article-title":"Global prevalence and clinical characteristics of metabolic associated fatty liver disease: a meta-analysis and systematic review of 10,739,607 individuals","author":"Chan","year":"2022","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.cgh.2022.09.028_bib12","article-title":"Nomenclature dilemma of metabolic associated fatty liver disease (MAFLD): considerable proportions of MAFLD are metabolic healthy","author":"Park","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2022.09.028_bib13","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.jhep.2021.06.013","article-title":"Are the different MAFLD subtypes based on the inclusion criteria correlated with all-cause mortality?","volume":"75","author":"Chen","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2022.09.028_bib14","first-page":"71","article-title":"Diversity in NAFLD: a review of manifestations of nonalcoholic fatty liver disease in different ethnicities globally","volume":"9","author":"Han","year":"2021","journal-title":"Journal of Clinical and Translational Hepatology"},{"key":"10.1016\/j.cgh.2022.09.028_bib15","series-title":"MEC laboratory procedures manual","year":"2017"},{"key":"10.1016\/j.cgh.2022.09.028_bib16","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0140-6736(03)15268-3","article-title":"Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies","volume":"363","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.cgh.2022.09.028_bib17","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/apt.13012","article-title":"Fatty liver indices in the multiethnic United States National Health and Nutrition Examination Survey","volume":"41","author":"Ruhl","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2022.09.028_bib18","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-230X-6-33","article-title":"The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population","volume":"6","author":"Bedogni","year":"2006","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.cgh.2022.09.028_bib19","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","article-title":"2018 ESC\/ESH guidelines for the management of arterial hypertension","volume":"39","author":"Williams","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cgh.2022.09.028_bib20","unstructured":"NHANES 2017-2018 data documentation. Available at: https:\/\/wwwn.cdc.gov\/Nchs\/Nhanes\/2017-2018\/LUX_J.htm. Accessed August 11, 2021."},{"key":"10.1016\/j.cgh.2022.09.028_bib21","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1053\/j.gastro.2019.01.042","article-title":"Accuracy of FibroScan controlled attenuation parameter and liver stiffness measurement in assessing steatosis and fibrosis in patients with nonalcoholic fatty liver disease","volume":"156","author":"Eddowes","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2022.09.028_bib22","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.jhep.2020.12.035","article-title":"Change from NAFLD to MAFLD increases the awareness of fatty liver disease in primary care physicians and specialists","volume":"74","author":"Fouad","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2022.09.028_bib23","doi-asserted-by":"crossref","DOI":"10.1002\/hep.32499","article-title":"Are there outcome differences between NAFLD and metabolic-associated fatty liver disease?","author":"Younossi","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2022.09.028_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.eprac.2022.03.016","article-title":"Metabolic associated fatty liver disease increases the risk of systemic complications and mortality: a meta-analysis and systematic review of 12,620,736 individuals","author":"Quek","year":"2022","journal-title":"Endocr Pract"},{"key":"10.1016\/j.cgh.2022.09.028_bib25","article-title":"NAFLD versus MAFLD: prevalence, outcomes and implications of a change in name","author":"Ng","year":"2022","journal-title":"Korean J Hepatol"},{"key":"10.1016\/j.cgh.2022.09.028_bib26","article-title":"Comparative burden of metabolic dysfunction in lean NAFLD vs non-lean NAFLD: a systematic review and meta-analysis","author":"Tang","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2022.09.028_bib27","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1053\/j.gastro.2021.07.049","article-title":"Clinical care pathway for the risk stratification and management of patients with nonalcoholic fatty liver disease","volume":"161","author":"Kanwal","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2022.09.028_bib28","article-title":"Mortality outcomes by fibrosis stage in nonalcoholic fatty liver disease: a systematic review and meta-analysis","author":"Ng","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2022.09.028_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/nu8060320","article-title":"Does metabolically healthy obesity exist?","volume":"8","author":"Mu\u00f1oz-Garach","year":"2016","journal-title":"Nutrients"},{"key":"10.1016\/j.cgh.2022.09.028_bib30","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/j.jacc.2018.02.055","article-title":"Metabolically healthy obesity, transition to metabolic syndrome, and cardiovascular risk","volume":"71","author":"Mongraw-Chaffin","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cgh.2022.09.028_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.773342","article-title":"Association between diabetes mellitus and all-cause and cardiovascular mortality among individuals with ultrasound-defined non-alcoholic fatty liver disease","volume":"12","author":"Wu","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.cgh.2022.09.028_bib32","doi-asserted-by":"crossref","DOI":"10.3350\/cmh.2022.0070","article-title":"NAFLD versus MAFLD: prevalence, outcomes and implications of a change in name","author":"Ng","year":"2022","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.cgh.2022.09.028_bib33","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1007\/s12072-020-10094-2","article-title":"The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease","volume":"14","author":"Eslam","year":"2020","journal-title":"Hepatology International"},{"key":"10.1016\/j.cgh.2022.09.028_bib34","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1111\/apt.12963","article-title":"Performance and limitations of steatosis biomarkers in patients with nonalcoholic fatty liver disease","volume":"40","author":"Fedchuk","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2022.09.028_bib35","doi-asserted-by":"crossref","DOI":"10.3350\/cmh.2022.0096","article-title":"The effect of diabetes and prediabetes on the prevalence, complications and mortality in non-alcoholic fatty liver disease","author":"Ng","year":"2022","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.cgh.2022.09.028_bib36","article-title":"The Fibrosis-4 (FIB-4) index predicts cardiovascular major adverse events and mortality in patients with non-alcoholic fatty liver disease","author":"Chew","year":"2022","journal-title":"Can J Cardiol"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356522009260?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356522009260?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:44:13Z","timestamp":1761543853000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356522009260"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":36,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S1542356522009260"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2022.09.028","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Spectrum and Impact of Metabolic Dysfunction in MAFLD: A Longitudinal Cohort Analysis of 32,683 Overweight and Obese Individuals","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2022.09.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by the AGA Institute","name":"copyright","label":"Copyright"}]}}